HEMGENIX OPTIONS

Number of suitable patients: CDEC talked over the uncertainty in the volume of people with reasonably critical to critical hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some clients who're categorized as owning moderate or reasonable ailment could have a extreme bleeding phenotype, wh